HOUSTON, Jan. 28, 2016 -- NightCulture, Inc. (OTCBB:NGHT) & Disco Donnie Presents are pleased to announce the complete artist line up for the Something Wonderful Music Festival. The festival starts its engines at the Texas Motor Speedway, Saturday, April 23, 2016 in Dallas/Ft.Worth, TX.
View the Complete Artist Lineup: http://www.SomethingWonderful.com
Michael Long, CEO of NightCulture, stated, "We are thrilled with this year’s Something Wonderful line up as it offers up some of the largest and most recognized names in Electronic Dance Music today."
ABOUT NIGHTCULTURE INC.
NightCulture Inc. (OTCQB:NGHT) is a premier producer of Electronic Dance Music (EDM) shows and festivals. NightCulture operates in the following markets: Houston, San Antonio, Austin, & Dallas/Ft.Worth, TX. NightCulture was the first Electronic Music company to trade in the public markets. http://www.NightCulture.com
NightCulture Inc. produces two major music festivals. "Something Wicked" Halloween Festival, which drew over 40,000 fans 2014 in Houston, TX http://www.SomethingWicked.com and "Something Wonderful" Festival in Dallas/Ft.Worth, TX which debuted in 2015. http://www.SomethingWonderful.com
Stereo Live, LLC, is a wholly-owned subsidiary of NightCulture which operates Stereo Live, a 25,000 square foot music and live events venue located at 6400 Richmond Avenue in Houston, Texas. http://www.StereoLiveHouston.com.
ABOUT DISCO DONNIE PRESENTS
Disco Donnie Presents (DDP) is an award-winning and recognized leader in electronic dance music event production, generating over 1,000 live events, arena shows and outdoor festivals annually. DDP, both on its own and through partnership, develops innovative, creative and strategic business opportunities in live entertainment. For more information, please visit www.discodonniepresents.com
Safe Harbor Statement
Statements in this release that relate to future plans or projected results of NightCulture Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended by the Private Securities Litigation Reform Act of 1995 (the "PSLRA"), and Section 21E of the Securities Exchange Act of 1934, as amended by the PSLRA, and all such statements fall under the "safe harbor" provisions of the PSLRA. Our actual results may vary materially from those described in any "forward-looking statement" due to, among other possible reasons, the realization of any one or more of the risk factors described in our annual or quarterly reports, or in any of our other filings with the Securities and Exchange Commission. Readers of this release are encouraged to study all of our filings with the Securities and Exchange Commission. Readers of this release are cautioned not to put undue reliance on forward-looking statements.
CONTACT: Michael Long 832-535-9070 [email protected]


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



